Tuberculosis co-infection in HAART naive HIV infected children - an Indian study
Shah, I.; Katira, B.
Indian Journal of Pediatrics 76(9): 966-967
2009
ISSN/ISBN: 0973-7693 PMID: 19904517 DOI: 10.1007/s12098-009-0182-2Document Number: 220553
Document emailed within 0-6 h
Related Documents
Kannangai, R.; Ramalingam, S.; Vijayakumar, T.S.; Vincent, A.A.; Abraham, O.C.; Subramanian, S.; Rupali, P.; Mathai, D.; Jesudason, M.V.; Sridharan, G. 2003: The immunological and virological response in human immunodeficiency virus type-1 (HIV-1) infected Indian individuals on HAART therapy: a one-year follow up study Indian Journal of Medical Microbiology 21(4): 274-276Burda, S.T.; Viswanath, R.; Zhao, J.; Kinge, T.; Anyangwe, C.; Tinyami, E.T.; Haldar, B.; Powell, R.L.R.; Jarido, V.; Hewlett, I.K.; Nyambi, P.N. 2010: HIV-1 reverse transcriptase drug-resistance mutations in chronically infected individuals receiving or naïve to HAART in Cameroon Journal of Medical Virology 82(2): 187-196
Dondo, V.; Mujuru, H.A.; Nathoo, K.J.; Chirehwa, M.; Mufandaedza, Z. 2013: Renal abnormalities among HIV-infected, antiretroviral naive children, Harare, Zimbabwe: a cross-sectional study Bmc Pediatrics 13: 75
Venkatesh, K.K.; Srikrishnan, A.K.; Safren, S.A.; Triche, E.W.; Thamburaj, E.; Prasad, L.; Lurie, M.N.; Kumar, M.Suresh.; Kumarasamy, N.; Solomon, S.; Mayer, K.H. 2011: Sexual risk behaviors among HIV-infected South Indian couples in the HAART era: implications for reproductive health and HIV care delivery Aids Care 23(6): 722-733
Karmakar, S.; Sharma, S.K.; Vashishtha, R.; Sharma, A.; Ranjan, S.; Gupta, D.; Sreenivas, V.; Sinha, S.; Biswas, A.; Gulati, V. 2011: Clinical characteristics of tuberculosis-associated immune reconstitution inflammatory syndrome in North Indian population of HIV/AIDS patients receiving HAART Clinical and Developmental Immunology 2011: 239021
Parakh, A.; Dubey, A.P.; Kumar, A.; Maheshwari, A.; Saxena, R. 2009: Efficacy of first-line, WHO recommended generic HAART regimens in Indian children Kathmandu University Medical Journal 7(27): 220-225
Rainwater-Lovett, K.; Moss, W.J. 2011: Immunologic basis for revaccination of HIV-infected children receiving HAART Future Virology 6(1): 59-71
Tseng, S.-H.; Jiang, D.D.-S.; Hoi, H.-S.; Yang, S.-L.; Hwang, K.-P. 2009: Impact of HAART therapy on co-infection of tuberculosis and HIV cases for 9 years in Taiwan American Journal of Tropical Medicine and Hygiene 80(4): 675-677
Nyesigire Ruhinda, E.; Bajunirwe, F.; Kiwanuka, J. 2012: Anaemia in HIV-infected children: severity, types and effect on response to HAART Bmc Pediatrics 12: 170
Shahapur, P.R.; Bairy, I.; Shivananda, P.G. 2005: Effect of "HAART" on CD4+ T lymphocyte counts in HIV seropositive south-Indian individuals--a follow up study Indian Journal of Pathology and Microbiology 48(2): 270-272
Kumarasamy, N.; Venkatesh, K.K.; Devaleenol, B.; Poongulali, S.; Mothi, S.N.; Solomon, S. 2009: Safety, tolerability and effectiveness of generic HAART in HIV-infected children in South India Journal of Tropical Pediatrics 55(3): 155-159
Akinbo, F.O.; Omoregie, R. 2012: Plasmodium falciparum infection in HIV-infected patients on highly active antiretroviral therapy (HAART) in Benin City, Nigeria Journal of Research in Health Sciences 12(1): 15-18
Shiri, T.; Auranen, K.; Nunes, M.C.; Adrian, P.V.; van Niekerk, N.; de Gouveia, L.; von Gottberg, A.; Klugman, K.P.; Madhi, S.A. 2013: Dynamics of pneumococcal transmission in vaccine-naive children and their HIV-infected or HIV-uninfected mothers during the first 2 years of life American journal of epidemiology 178(11): 1629-1637
Siegfried, N.; Davies, M-Ann.; Penazzato, M.; Muhe, L.M.; Egger, M. 2013: Optimal time for initiating antiretroviral therapy (ART) in HIV-infected, treatment-naive children aged 2 to 5 years old Cochrane Database of Systematic Reviews 2013(10): Cd010309
Lapphra, K.; Vanprapar, N.; Phongsamart, W.; Chearskul, P.; Chokephaibulkit, K. 2005: Dyslipidemia and lipodystrophy in HIV-infected Thai children on highly active antiretroviral therapy (HAART) Journal of the Medical Association of Thailand 88(7): 956-966
Prakash, S.S.; Andrabi, R.; Kumar, R.; Lodha, R.; Kabra, S.K.; Vajpayee, M.; Luthra, K. 2012: Antibodies that cross-neutralize the tier-2 pseudoviruses are produced in antiretroviral-naïve HIV-1-infected children from northern India Archives of Virology 157(9): 1797-1801
Sophan, S.; Meng, C.Y.; Pean, P.; Harwell, J.; Hutton, E.; Trzmielina, S.; Somasundaran, M.; Luzuriaga, K.; Pugatch, D. 2010: Virologic and immunologic outcomes in HIV-infected Cambodian children after 18 months of highly active antiretroviral therapy (HAART) Southeast Asian Journal of Tropical Medicine and Public Health 41(1): 126-137
Sophan, S.; Meng, C.Y.; Pean, P.; Harwell, J.; Hutton, E.; Trzmielina, S.; Somasundaran, M.; Luzuriaga, K.; Pugatch, D. 2010: Virologic and immunologic outcomes in HIV-infected Cambodian children after 18 months of highly active antiretroviral therapy (HAART) Southeast Asian Journal of Tropical Medicine and Public Health 41(1): 126-137
Raffi, F.; Reliquet, V.; Ferré, V.; Arvieux, C.; Hascoet, C.; Bellein, V.; Besnier, J.M.; Breux, J.P.; Garré, M.; May, T.; Molina, J.M.; Perré, P.; Raguin, G.; Rozenbaum, W.; Zucman, D. 2000: The VIRGO study: nevirapine, didanosine and stavudine combination therapy in antiretroviral-naive HIV-1-infected adults Antiviral Therapy 5(4): 267-272
Pedrozo, C.; Sant'Anna, C.; de Fátima March, M.; Lucena, S. 2009: Clinical scoring system for paediatric tuberculosis in HIV-infected and non-infected children in Rio de Janeiro International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 13(3): 413-415